Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007. Kelyniam Global, Inc. was incorporated in 2005 and is based in Canton, Connecticut.
Frequently asked questions
What sector does Kelyniam Global Inc (KLYG) operate in?
Kelyniam Global Inc belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Kelyniam Global Inc (KLYG) current stock price?
As of the latest data, Kelyniam Global Inc stock price is $0.10, with a previous close of $0.10.
What is Kelyniam Global Inc (KLYG) current market capitalization?
Kelyniam Global Inc market cap is approximately 5.06 million.
What is Kelyniam Global Inc (KLYG) EBITDA?
Kelyniam Global Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -108.69 thousand.
Does Kelyniam Global Inc (KLYG) pay dividends?
No. Kelyniam Global Inc does not pay a dividend.
What is Kelyniam Global Inc (KLYG) beta (volatility) score?
Kelyniam Global Inc has a beta of 0.323, indicating lower volatility than the overall market.